Senior Director, Specialty Clinical Solutions
Magellan Rx Management a Prime Therapeutics Company
Wakefield, Rhode Island
(D3) Evaluating Biosimilar Real-World Evidence, Ongoing Trends, and Market Expansion in Rheumatology
Tuesday, April 16, 2024
3:15 PM – 4:30 PM CT